Iovance Biotherapeutics, Inc.
IOVA
Cena:
$ 4.11
+0.41 (11.08%)
Valuace
70
Růst
30
Zdraví
50
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 31.1 mil | 8.70% | 0.00% | 0.00% | 2024-09-30 |
| MHR FUND MANAGEMENT LLC | 29.0 mil | 8.11% | 0.63% | 7.43% | 2022-12-31 |
| BLACKROCK INC. | 21.2 mil | 7.97% | 0.00% | 0.00% | 2017-06-30 |
| BLACKROCK FUNDING, INC. /DE | 23.5 mil | 7.74% | 0.00% | 0.00% | 2024-09-30 |
| VANGUARD GROUP INC | 27.2 mil | 7.47% | 0.00% | 0.00% | 2017-06-30 |
| STATE STREET CORP | 17.4 mil | 4.88% | 0.00% | 0.00% | 2017-06-30 |
| PERCEPTIVE ADVISORS LLC | 12.7 mil | 3.94% | -3.02% | 1.49% | 2017-06-30 |
| TWO SIGMA INVESTMENTS, LP | 13.7 mil | 3.83% | 0.02% | 0.04% | 2024-06-30 |
| 11.7 mil | 3.27% | 0.00% | 0.00% | 2026-03-31 | |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 9.2 mil | 2.85% | -0.46% | 0.52% | 2023-06-30 |
| MILLENNIUM MANAGEMENT LLC | 9.4 mil | 2.63% | 0.01% | 0.01% | 2021-12-31 |
| GOLDMAN SACHS GROUP INC | 8.8 mil | 2.45% | 0.00% | 0.00% | 2017-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 8.6 mil | 2.40% | 0.00% | 0.00% | 2017-06-30 |
| INVENOMIC CAPITAL MANAGEMENT LP | 8.5 mil | 2.38% | -0.15% | 1.37% | 2025-03-31 |
| BANK OF AMERICA CORP /DE/ | 8.5 mil | 2.38% | 0.00% | 0.00% | 2017-06-30 |
| D. E. SHAW & CO., INC. | 8.0 mil | 2.24% | 0.01% | 0.02% | 2019-12-31 |
| ORBIMED ADVISORS LLC | 4.7 mil | 1.92% | 0.31% | 0.77% | 2017-06-30 |
| PALO ALTO INVESTORS LP | 6.3 mil | 1.78% | 0.70% | 3.41% | 2023-12-31 |
| MORGAN STANLEY | 6.2 mil | 1.74% | 0.00% | 0.00% | 2017-06-30 |
| MACQUARIE GROUP LTD | 4.8 mil | 1.48% | -0.02% | 0.02% | 2024-03-31 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 4.4 mil | 1.37% | -0.03% | 0.02% | 2019-06-30 |
| JANE STREET GROUP, LLC | 4.2 mil | 1.17% | 0.00% | 0.00% | 2019-06-30 |
| AVORO CAPITAL ADVISORS LLC | 3.5 mil | 1.15% | -0.21% | 0.37% | 2017-06-30 |
| NUVEEN, LLC | 3.7 mil | 1.03% | 0.00% | 0.00% | 2025-03-31 |
| HRT FINANCIAL LP | 3.5 mil | 0.98% | -0.01% | 0.03% | 2025-03-31 |
| PRINCIPAL FINANCIAL GROUP INC | 3.0 mil | 0.90% | 0.00% | 0.00% | 2018-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.2 mil | 0.89% | 0.00% | 0.00% | 2018-03-31 |
| BIOIMPACT CAPITAL LLC | 2.7 mil | 0.84% | -1.26% | 1.55% | 2022-06-30 |
| TWO SIGMA ADVISERS, LP | 3.0 mil | 0.83% | 0.01% | 0.02% | 2025-06-30 |
| NORTHERN TRUST CORP | 2.9 mil | 0.80% | 0.00% | 0.00% | 2017-06-30 |
| MAN GROUP PLC | 2.4 mil | 0.80% | 0.05% | 0.05% | 2024-12-31 |
| CREDIT SUISSE AG/ | 2.0 mil | 0.78% | 0.01% | 0.03% | 2017-06-30 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.8 mil | 0.78% | 0.00% | 0.00% | 2017-06-30 |
| CAPTION MANAGEMENT, LLC | 1.8 mil | 0.74% | 0.14% | 0.20% | 2019-06-30 |
| DIMENSIONAL FUND ADVISORS LP | 2.6 mil | 0.74% | 0.00% | 0.00% | 2018-09-30 |
| JPMORGAN CHASE & CO | 2.5 mil | 0.70% | 0.00% | 0.00% | 2017-06-30 |
| MARSHALL WACE, LLP | 2.4 mil | 0.66% | 0.01% | 0.01% | 2026-03-31 |
| VANGUARD FIDUCIARY TRUST CO | 2.2 mil | 0.61% | 0.00% | 0.00% | 2026-03-31 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 1.9 mil | 0.60% | -0.02% | 0.00% | 2024-03-31 |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 2.1 mil | 0.59% | -0.42% | 0.19% | 2021-12-31 |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 1.6 mil | 0.58% | -1.03% | 0.48% | 2024-03-31 |
| WELLS FARGO & COMPANY/MN | 2.1 mil | 0.58% | 0.00% | 0.00% | 2017-06-30 |
| ORION INVESTMENT CO | 2.1 mil | 0.58% | 0.76% | 2.30% | 2024-06-30 |
| ASSENAGON ASSET MANAGEMENT S.A. | 1.7 mil | 0.58% | 0.02% | 0.02% | 2024-12-31 |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 2.1 mil | 0.58% | 0.48% | 0.89% | 2017-06-30 |
| NUVEEN ASSET MANAGEMENT, LLC | 1.7 mil | 0.56% | 0.00% | 0.00% | 2019-03-31 |
| BRAIDWELL LP | 1.5 mil | 0.55% | 0.05% | 0.37% | 2024-03-31 |
| UBS GROUP AG | 1.9 mil | 0.54% | 0.00% | 0.00% | 2017-06-30 |
| RAYMOND JAMES FINANCIAL INC | 1.6 mil | 0.52% | 0.00% | 0.00% | 2024-12-31 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.7 mil | 0.48% | 0.00% | 0.00% | 2017-06-30 |
| ROYAL BANK OF CANADA | 1.6 mil | 0.46% | 0.00% | 0.00% | 2017-06-30 |
| BALYASNY ASSET MANAGEMENT L.P. | 1.5 mil | 0.45% | 0.00% | 0.00% | 2020-03-31 |
| KNOTT DAVID M JR | 1.6 mil | 0.45% | 3.34% | 3.34% | 2026-03-31 |
| EAGLE ASSET MANAGEMENT INC | 1.4 mil | 0.45% | -0.01% | 0.07% | 2023-12-31 |
| RICE HALL JAMES & ASSOCIATES, LLC | 1.5 mil | 0.42% | 0.08% | 0.30% | 2020-03-31 |
| B GROUP, INC. | 1.5 mil | 0.42% | 0.88% | 3.90% | 2024-12-31 |
| SCHONFELD STRATEGIC ADVISORS LLC | 1.0 mil | 0.42% | 0.06% | 0.06% | 2022-09-30 |
| LOGOS GLOBAL MANAGEMENT LP | 0.00 mld | 0.41% | 0.15% | 0.76% | 2023-09-30 |
| INVESCO LTD. | 1.4 mil | 0.40% | 0.00% | 0.00% | 2019-06-30 |
| APIS CAPITAL ADVISORS, LLC | 1.3 mil | 0.40% | -4.66% | 2.06% | 2024-09-30 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.3 mil | 0.39% | 0.02% | 0.02% | 2025-03-31 |
| ARTAL GROUP S.A. | 1.0 mil | 0.38% | 0.21% | 0.21% | 2024-06-30 |
| SIREN, L.L.C. | 1.1 mil | 0.36% | -0.16% | 0.36% | 2024-09-30 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 1.2 mil | 0.36% | 0.04% | 0.04% | 2025-03-31 |
| WOODLINE PARTNERS LP | 1.3 mil | 0.36% | 0.01% | 0.02% | 2023-09-30 |
| NORGES BANK | 942.98 tis | 0.35% | 0.00% | 0.00% | 2024-06-30 |
| C WORLDWIDE GROUP HOLDING A/S | 1.3 mil | 0.35% | 0.03% | 0.09% | 2022-06-30 |
| NEW YORK STATE COMMON RETIREMENT FUND | 1.1 mil | 0.35% | -0.01% | 0.01% | 2017-06-30 |
| OPALEYE MANAGEMENT INC. | 897.00 tis | 0.34% | -1.25% | 1.64% | 2023-03-31 |
| STEMPOINT CAPITAL LP | 949.40 tis | 0.31% | 1.75% | 1.75% | 2024-12-31 |
| BARCLAYS PLC | 1.1 mil | 0.31% | 0.00% | 0.00% | 2017-09-30 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 972.69 tis | 0.30% | 0.00% | 0.00% | 2022-12-31 |
| MIRADOR CAPITAL PARTNERS LP | 1.1 mil | 0.30% | 0.15% | 0.53% | 2025-09-30 |
| CUTTER CAPITAL MANAGEMENT, LP | 876.01 tis | 0.29% | 2.43% | 2.43% | 2024-09-30 |
| SQUAREPOINT OPS LLC | 1.0 mil | 0.29% | 0.00% | 0.00% | 2024-06-30 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1.0 mil | 0.29% | 0.01% | 0.01% | 2026-03-31 |
| PICTET ASSET MANAGEMENT HOLDING SA | 920.46 tis | 0.29% | 0.00% | 0.00% | 2023-09-30 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.00 mld | 0.28% | 0.14% | 0.14% | 2022-06-30 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 897.35 tis | 0.27% | 0.00% | 0.00% | 2023-12-31 |
| BANK OF NEW YORK MELLON CORP | 956.78 tis | 0.27% | 0.00% | 0.00% | 2017-06-30 |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 914.45 tis | 0.26% | 0.01% | 0.05% | 2025-09-30 |
| ALLIANCEBERNSTEIN L.P. | 765.40 tis | 0.25% | 0.00% | 0.00% | 2017-06-30 |
| SECTOR GAMMA AS | 900.00 tis | 0.25% | 0.75% | 0.75% | 2026-03-31 |
| BANQUE PICTET & CIE SA | 668.65 tis | 0.25% | -0.05% | 0.05% | 2021-03-31 |
| BOXER CAPITAL, LLC | 750.00 tis | 0.25% | 0.03% | 0.35% | 2021-09-30 |
| GSA CAPITAL PARTNERS LLP | 872.99 tis | 0.24% | 0.19% | 0.21% | 2024-03-31 |
| WALLEYE CAPITAL LLC | 822.75 tis | 0.23% | 0.01% | 0.01% | 2025-09-30 |
| CITIGROUP INC | 714.85 tis | 0.21% | 0.00% | 0.00% | 2017-06-30 |
| CITADEL ADVISORS LLC | 759.00 tis | 0.21% | 0.00% | 0.00% | 2017-12-31 |
| CM MANAGEMENT, LLC | 700.00 tis | 0.21% | 0.17% | 1.27% | 2023-09-30 |
| ABRDN PLC | 759.52 tis | 0.21% | 0.00% | 0.00% | 2024-06-30 |
| DEUTSCHE BANK AG\ | 734.96 tis | 0.21% | 0.00% | 0.00% | 2017-06-30 |
| UBS ASSET MANAGEMENT AMERICAS INC | 657.21 tis | 0.20% | 0.00% | 0.00% | 2017-06-30 |
| VOSS CAPITAL, LLC | 650.00 tis | 0.19% | -0.01% | 0.07% | 2025-06-30 |
| RAFFERTY ASSET MANAGEMENT, LLC | 706.45 tis | 0.19% | 0.00% | 0.01% | 2019-03-31 |
| QVT FINANCIAL LP | 678.56 tis | 0.19% | 0.02% | 0.17% | 2017-06-30 |
| CANDRIAM S.C.A. | 500.03 tis | 0.19% | -0.08% | 0.02% | 2019-06-30 |
| SG AMERICAS SECURITIES, LLC | 498.39 tis | 0.19% | 0.02% | 0.02% | 2023-06-30 |
| CAPITAL FUND MANAGEMENT S.A. | 599.87 tis | 0.19% | 0.00% | 0.01% | 2024-06-30 |
| QUINN OPPORTUNITY PARTNERS LLC | 614.20 tis | 0.18% | 0.09% | 0.09% | 2025-06-30 |
| 683 CAPITAL MANAGEMENT, LLC | 644.30 tis | 0.18% | 0.12% | 0.12% | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 651.00 tis | 0.18% | 0.00% | 0.00% | 2025-03-31 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 628.54 tis | 0.18% | 0.00% | 0.00% | 2025-09-30 |
| BNP PARIBAS ARBITRAGE, SNC | 464.05 tis | 0.17% | 0.00% | 0.00% | 2017-06-30 |
| VOLEON CAPITAL MANAGEMENT LP | 630.26 tis | 0.17% | 0.03% | 0.04% | 2025-06-30 |
| LPL FINANCIAL LLC | 623.07 tis | 0.17% | 0.00% | 0.00% | 2020-09-30 |
| GROUP ONE TRADING, L.P. | 553.47 tis | 0.17% | 0.00% | 0.00% | 2020-09-30 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 544.35 tis | 0.16% | 0.01% | 0.04% | 2021-12-31 |
| TANG CAPITAL MANAGEMENT LLC | 543.76 tis | 0.16% | -0.11% | 0.05% | 2023-12-31 |
| SWISS NATIONAL BANK | 501.16 tis | 0.15% | 0.00% | 0.00% | 2017-06-30 |
| RHUMBLINE ADVISERS | 368.80 tis | 0.14% | 0.00% | 0.00% | 2017-06-30 |
| PANAGORA ASSET MANAGEMENT INC | 361.19 tis | 0.14% | -0.01% | 0.01% | 2023-03-31 |
| AMERICAN CENTURY COMPANIES INC | 338.52 tis | 0.13% | 0.00% | 0.00% | 2019-09-30 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 335.51 tis | 0.13% | 0.00% | 0.00% | 2022-03-31 |
| TUDOR INVESTMENT CORP ET AL | 299.89 tis | 0.11% | -0.01% | 0.01% | 2021-03-31 |
| TD ASSET MANAGEMENT INC | 284.88 tis | 0.11% | 0.00% | 0.00% | 2018-03-31 |
| SEI INVESTMENTS CO | 284.76 tis | 0.11% | 0.00% | 0.00% | 2019-03-31 |
| PARAMETRICA MANAGEMENT LTD | 261.09 tis | 0.10% | -0.04% | 2.77% | 2021-06-30 |
| LEGAL & GENERAL GROUP PLC | 242.92 tis | 0.09% | 0.00% | 0.00% | 2017-06-30 |
| STATE OF WISCONSIN INVESTMENT BOARD | 236.37 tis | 0.09% | 0.00% | 0.01% | 2017-06-30 |
| NEO IVY CAPITAL MANAGEMENT | 212.65 tis | 0.08% | 0.33% | 0.33% | 2024-06-30 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| Kirby Daniel Gordon | officer: Chief Commercial Officer | M-Exempt | 10000 | 0.00 | 13.5 2026 | 70004 |
| Kirby Daniel Gordon | officer: Chief Commercial Officer | F-InKind | 2435 | 3.70 | 13.5 2026 | 146946 |
| Kirby Daniel Gordon | officer: Chief Commercial Officer | M-Exempt | 10000 | 0.00 | 13.5 2026 | 149381 |
| BILINSKY IGOR | officer: Chief Operating Officer | A-Award | 117500 | 0.00 | 11.3 2026 | 117500 |
| Kirby Daniel Gordon | officer: Chief Commercial Officer | A-Award | 132200 | 0.00 | 11.3 2026 | 132200 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | A-Award | 58750 | 0.00 | 11.3 2026 | 58750 |
| Puri Raj K. | officer: Chief Regulatory Officer | A-Award | 117500 | 0.00 | 11.3 2026 | 117500 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | A-Award | 235000 | 0.00 | 11.3 2026 | 235000 |
| Roche Corleen M. | officer: Chief Financial Officer | A-Award | 132200 | 0.00 | 11.3 2026 | 132200 |
| BILINSKY IGOR | officer: Chief Operating Officer | M-Exempt | 31246 | 0.00 | 6.3 2026 | 62504 |
| BILINSKY IGOR | officer: Chief Operating Officer | F-InKind | 16628 | 4.58 | 6.3 2026 | 125766 |
| BILINSKY IGOR | officer: Chief Operating Officer | M-Exempt | 31246 | 0.00 | 6.3 2026 | 142394 |
| Puri Raj K. | officer: Chief Regulatory Officer | M-Exempt | 39059 | 0.00 | 6.3 2026 | 78131 |
| Puri Raj K. | officer: Chief Regulatory Officer | F-InKind | 18360 | 4.58 | 6.3 2026 | 239230 |
| Puri Raj K. | officer: Chief Regulatory Officer | M-Exempt | 39059 | 0.00 | 6.3 2026 | 257590 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | M-Exempt | 31246 | 0.00 | 6.3 2026 | 62504 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | F-InKind | 16520 | 4.58 | 6.3 2026 | 131957 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | M-Exempt | 31246 | 0.00 | 6.3 2026 | 148477 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | M-Exempt | 62493 | 0.00 | 6.3 2026 | 125007 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | F-InKind | 26755 | 4.58 | 6.3 2026 | 529538 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | M-Exempt | 62493 | 0.00 | 6.3 2026 | 556293 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | M-Exempt | 3907 | 0.00 | 4.3 2026 | 0 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | M-Exempt | 8790 | 0.00 | 4.3 2026 | 35159 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | F-InKind | 7122 | 3.79 | 4.3 2026 | 117231 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | M-Exempt | 12697 | 0.00 | 4.3 2026 | 124353 |
| Puri Raj K. | officer: Chief Regulatory Officer | M-Exempt | 5470 | 0.00 | 4.3 2026 | 21878 |
| Puri Raj K. | officer: Chief Regulatory Officer | F-InKind | 2798 | 3.79 | 4.3 2026 | 218531 |
| Puri Raj K. | officer: Chief Regulatory Officer | M-Exempt | 5470 | 0.00 | 4.3 2026 | 221329 |
| BILINSKY IGOR | officer: Chief Operating Officer | M-Exempt | 3517 | 0.00 | 4.3 2026 | 0 |
| BILINSKY IGOR | officer: Chief Operating Officer | M-Exempt | 8790 | 0.00 | 4.3 2026 | 35159 |
| BILINSKY IGOR | officer: Chief Operating Officer | F-InKind | 6903 | 3.79 | 4.3 2026 | 111148 |
| BILINSKY IGOR | officer: Chief Operating Officer | M-Exempt | 12307 | 0.00 | 4.3 2026 | 118051 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | M-Exempt | 10418 | 0.00 | 4.3 2026 | 0 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | M-Exempt | 41669 | 0.00 | 4.3 2026 | 166675 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | F-InKind | 22809 | 3.79 | 4.3 2026 | 493800 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | M-Exempt | 52087 | 0.00 | 4.3 2026 | 516609 |
| Kirby Daniel Gordon | officer: Chief Commercial Officer | M-Exempt | 150000 | 0.00 | 26.2 2026 | 0 |
| Kirby Daniel Gordon | officer: Chief Commercial Officer | F-InKind | 34165 | 3.78 | 26.2 2026 | 139381 |
| Kirby Daniel Gordon | officer: Chief Commercial Officer | M-Exempt | 120000 | 0.00 | 26.2 2026 | 173546 |
| Kirby Daniel Gordon | officer: Chief Commercial Officer | F-InKind | 16450 | 2.60 | 12.2 2026 | 53546 |
| Kirby Daniel Gordon | officer: Chief Commercial Officer | M-Exempt | 39996 | 0.00 | 12.2 2026 | 69996 |
| Kirby Daniel Gordon | officer: Chief Commercial Officer | M-Exempt | 39996 | 0.00 | 12.2 2026 | 80004 |
| Puri Raj K. | officer: Chief Regulatory Officer | M-Exempt | 5469 | 0.00 | 3.12 2025 | 27348 |
| Puri Raj K. | officer: Chief Regulatory Officer | F-InKind | 2467 | 2.23 | 3.12 2025 | 215859 |
| Puri Raj K. | officer: Chief Regulatory Officer | M-Exempt | 5469 | 0.00 | 3.12 2025 | 218326 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | M-Exempt | 10417 | 0.00 | 3.12 2025 | 10418 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | M-Exempt | 41669 | 0.00 | 3.12 2025 | 208344 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | F-InKind | 17701 | 2.23 | 3.12 2025 | 458531 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | F-InKind | 4426 | 2.14 | 3.12 2025 | 464522 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | M-Exempt | 10417 | 0.00 | 3.12 2025 | 468948 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | M-Exempt | 41669 | 0.00 | 3.12 2025 | 476232 |
| BILINSKY IGOR | officer: Chief Operating Officer | M-Exempt | 3516 | 0.00 | 3.12 2025 | 3517 |
| BILINSKY IGOR | officer: Chief Operating Officer | M-Exempt | 8789 | 0.00 | 3.12 2025 | 43949 |
| BILINSKY IGOR | officer: Chief Operating Officer | F-InKind | 4464 | 2.23 | 3.12 2025 | 104014 |
| BILINSKY IGOR | officer: Chief Operating Officer | F-InKind | 1786 | 2.14 | 3.12 2025 | 105744 |
| BILINSKY IGOR | officer: Chief Operating Officer | M-Exempt | 3516 | 0.00 | 3.12 2025 | 107530 |
| BILINSKY IGOR | officer: Chief Operating Officer | M-Exempt | 8789 | 0.00 | 3.12 2025 | 108478 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | M-Exempt | 3906 | 0.00 | 3.12 2025 | 3907 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | M-Exempt | 8789 | 0.00 | 3.12 2025 | 43949 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | F-InKind | 4464 | 2.23 | 3.12 2025 | 109734 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | F-InKind | 1984 | 2.14 | 3.12 2025 | 111656 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | M-Exempt | 3906 | 0.00 | 3.12 2025 | 113640 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | M-Exempt | 8789 | 0.00 | 3.12 2025 | 114198 |
| BILINSKY IGOR | officer: Chief Operating Officer | M-Exempt | 3516 | 0.00 | 4.9 2025 | 7033 |
| BILINSKY IGOR | officer: Chief Operating Officer | M-Exempt | 8790 | 0.00 | 4.9 2025 | 52738 |
| BILINSKY IGOR | officer: Chief Operating Officer | F-InKind | 6250 | 2.19 | 4.9 2025 | 99689 |
| BILINSKY IGOR | officer: Chief Operating Officer | M-Exempt | 12306 | 0.00 | 4.9 2025 | 105939 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | M-Exempt | 3907 | 0.00 | 4.9 2025 | 7813 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | M-Exempt | 8790 | 0.00 | 4.9 2025 | 52738 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | F-InKind | 6448 | 2.19 | 4.9 2025 | 105409 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | M-Exempt | 12697 | 0.00 | 4.9 2025 | 111857 |
| Puri Raj K. | officer: Chief Regulatory Officer | M-Exempt | 5470 | 0.00 | 4.9 2025 | 32817 |
| Puri Raj K. | officer: Chief Regulatory Officer | F-InKind | 2467 | 2.19 | 4.9 2025 | 212857 |
| Puri Raj K. | officer: Chief Regulatory Officer | M-Exempt | 5470 | 0.00 | 4.9 2025 | 215324 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | M-Exempt | 10417 | 0.00 | 4.9 2025 | 20385 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | M-Exempt | 41669 | 0.00 | 4.9 2025 | 250013 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | F-InKind | 22127 | 2.19 | 4.9 2025 | 434563 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | M-Exempt | 52086 | 0.00 | 4.9 2025 | 456690 |
| Roche Corleen M. | officer | 0 | 0.00 | 8.8 2025 | 0 | |
| Roche Corleen M. | officer: Chief Financial Officer | A-Award | 150000 | 0.00 | 8.8 2025 | 150000 |
| Roche Corleen M. | officer: Chief Financial Officer | A-Award | 300000 | 2.58 | 8.8 2025 | 300000 |
| Rosinack Matthew W. | officer: SVP, Finance (Int. PFO & PAO) | 59060 | 0.00 | 10.7 2025 | 0 | |
| Rosinack Matthew W. | officer: SVP, Finance (Int. PFO & PAO) | 75000 | 25.30 | 10.7 2025 | 0 | |
| Rosinack Matthew W. | officer: SVP, Finance (Int. PFO & PAO) | 0 | 0.00 | 10.7 2025 | 89129 | |
| YARNO WENDY L | director | A-Award | 67546 | 0.00 | 17.6 2025 | 67546 |
| Dukes Iain D. | director | A-Award | 135092 | 0.00 | 17.6 2025 | 135092 |
| WEISER MICHAEL | director | A-Award | 67546 | 0.00 | 17.6 2025 | 67546 |
| Maynard Ryan D | director | A-Award | 67546 | 0.00 | 17.6 2025 | 67546 |
| Countouriotis Athena | director | A-Award | 67546 | 0.00 | 17.6 2025 | 67546 |
| Kirby Daniel Gordon | officer: Chief Commercial Officer | P-Purchase | 30000 | 1.84 | 6.6 2025 | 30000 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | M-Exempt | 8789 | 0.00 | 4.6 2025 | 61528 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | F-InKind | 6448 | 1.76 | 4.6 2025 | 99160 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | M-Exempt | 12695 | 0.00 | 4.6 2025 | 105608 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | M-Exempt | 10417 | 0.00 | 4.6 2025 | 31252 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | M-Exempt | 41668 | 0.00 | 4.6 2025 | 291682 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | F-InKind | 22127 | 1.76 | 4.6 2025 | 404604 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | M-Exempt | 52085 | 0.00 | 4.6 2025 | 426731 |
| Puri Raj K. | officer: Chief Regulatory Officer | M-Exempt | 5469 | 0.00 | 4.6 2025 | 38287 |
| Puri Raj K. | officer: Chief Regulatory Officer | F-InKind | 2467 | 1.76 | 4.6 2025 | 209854 |
| Puri Raj K. | officer: Chief Regulatory Officer | M-Exempt | 5469 | 0.00 | 4.6 2025 | 212321 |
